Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or exon 21 mutations. This solution is of ramucirumab injection combined with erlotinib. This combination is now the first and only FDA-approved anti-VEGFR/EGFR TKI [...]
Alunbrig Gets FDA Approval for Frontline ALK-Positive Lung Cancer Patients
FDA has approved Alunbrig or Brigatinib for first-line treatment of patients with ALK-positive metastatic non-small cell lung cancer, as detected by FDA-approved test. This [...]
U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of the disease have received a new first-line treatment [...]
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most common type of [...]
Lung Cancer Patients May Face Risk of Death from COVID-19
The continuous fear of COVID-19 is on the rise. With more and more people getting trapped in this pandemic, it also offers risk to those who already have health issues. The [...]
Guidance on Lung Cancer Screening During COVID-19
In this time of COVID-19 pandemic, a new expert panel has provided guidance to clinicians managing lung cancer screening programs. This statement was published in journals [...]
Tackling Coronavirus during Lung Cancer Treatment
At the end of year 2019, a novel coronavirus was identified in Wuhan, a city in the Hubei Province of China. It spread rapidly and resulted in an increasing number of cases in [...]
Challenges for Lung Cancer Patients amid COVID 19
Coronavirus disease 2019, or COVID 19, has rapidly evolved into a worldwide pandemic. It has become a public health emergency of international concern. Irrespective of the [...]
Non-Smokers with COPD are at High Risk of Getting Lung Cancer
The most prominent factor behind getting lung cancer is smoking. In addition to smokers, non-smokers are also getting affected by this deadly disease. According to the recent [...]
New AI-Powered Blood Test to Detect Lung Cancer
One of the deadliest diseases is lung cancer which has affected people from all around the world. The earlier it is detected, the better chance of survival is a patient has. [...]
Combating Small Cell Lung Cancer with Upfront Immunotherapy Options
Lung Cancer is the second most common form of cancer worldwide. Small-cell lung cancer (SCLC) represents about 10% to 15% of all lung cancers. It is a form of neuroendocrine [...]
Researchers Identify Protein to Signal if NSCLC will Spread
Lung cancer is one of the deadliest cancers in men and women worldwide. The most prevalent form of lung cancer is non-small cell lung cancer (NSCLC). NSCLC tumors are [...]
Simple Diamond Gap Finger Test Could Reveal Signs of Lung Cancer
Early diagnosis of lung cancer helps to increase the survival rate among the patients. However, the most difficult part is identifying the disease at an early stage. Lung [...]
What to Consider Before Getting A Lung Cancer on Marijuana Medication?
Lung cancer is one of the major causes of death, particularly in the US. It has been found that more people die because of it as compared to other types of cancers. One of the [...]
Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. Pembrolizumab [...]